Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study (2021) Hoertel N, Sanchez-Rico M, Gulbins E, Kornhuber J, Carpinteiro A, Lenze EJ, Reiersen AM, et al. Journal article Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study (2021) Schlichtig K, Dürr P, Dörje F, Fromm M Journal article Clinical Aspects of Transporter-Mediated Drug–Drug Interactions (2019) Geßner A, König J, Fromm M Journal article, Review article Precision Medicine in Inflammatory Bowel Diseases (2017) Fischer S, Neurath M Journal article CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations (2014) Province MA, Goetz MP, Brauch H, Flockhare DA, Hebert JM, Whaley R, Suman VJ, et al. Journal article Inconsistencies and misleading information in officially approved prescribing information from three major drug markets (2014) Pfistermeister B, Saß A, Criegee-Rieck M, Bürkle T, Fromm M, Maas R Journal article Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects (2014) Misaka S, Yatabe J, Müller F, Takano K, Kawabe K, Gläser H, Yatabe MS, et al. Journal article Response to "the effect of green tea with exceptionally high catechin content on nadolol plasma concentration" (2014) Misaka S, Yatabe J, Müller F, Takano K, Gläser H, Yatabe MS, Onoue S, et al. Journal article, Letter Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans. (1995) Fromm M, Hofmann U, Griese U, Mikus G Journal article, Original article